Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$11.0 - $21.45 $1,903 - $3,710
-173 Reduced 85.64%
29 $0
Q3 2022

Oct 21, 2022

BUY
$20.09 - $35.8 $341 - $608
17 Added 9.19%
202 $4,000
Q2 2022

Aug 02, 2022

SELL
$27.42 - $43.63 $520 - $828
-19 Reduced 9.31%
185 $6,000
Q1 2022

May 02, 2022

BUY
$36.48 - $52.22 $656 - $939
18 Added 9.68%
204 $8,000
Q4 2021

Feb 03, 2022

BUY
$33.11 - $55.01 $430 - $715
13 Added 7.51%
186 $8,000
Q3 2021

Nov 09, 2021

BUY
$50.07 - $66.05 $8,662 - $11,426
173 New
173 $9,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $420M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Jfs Wealth Advisors, LLC Portfolio

Follow Jfs Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jfs Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jfs Wealth Advisors, LLC with notifications on news.